Professor of Medicine
Member of the Duke Cancer Institute
Email address
scott.antonia@duke.edu
Education and Training
- Postdoctoral Fellowship, Immunobiology, Yale University School of Medicine, 1992 - 1994
- Medical Oncology Fellowship, Yale University School of Medicine, 1991 - 1994
- Internal Medicine Residency, Yale University School of Medicine, 1989 - 1991
- M.D., University of Connecticut, School of Medicine, 1989
- Ph.D., University of Connecticut, School of Medicine, 1987
Grants
- Duke Center for Advancement of Child Health (CAtCH).
- Nektar PROPEL
- Clinical Biomarker Study of the Tumor NLRP3 Inflammasome and its Role in Anti-PD-1 Immunotherapy Resistance
- Anti-PD1 in combination with an inhibitor of PCSK9 to increase MHC class I molecule expression on tumor cells as immunotherapy for NSCLC
- CA191146: Long-acting PEG-like conjugates of an immune checkpoint inhibitor and a selective cytokine for combination immunotherapy
- Evaluating the Impact of PCSK9 on the Composition of the Tumor-Immune Microenvironment and Treatment Response to Immune Checkpoint Blockade in NSCLC
- Identifying Epigenetic Biomarkers that Predict Response to Immunotherapy in Lung Cancer Patients
- Anonymous Donation
- Tumor Infiltrating lymphocyte adoptive T cell therapy for NSCLC
- Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance